Betaine recovers hypothalamic neural injury by inhibiting astrogliosis and inflammation in fructose-fed rats

Molecular Nutrition and Food Research

Volumn 59, Issue 2, 2015, Pages 189-202

  Li, Jian Mei ^a   Ge, Chen Xu ^a   Xu, Min Xuan ^a   Wang, Wei ^a   Yu, Rong ^a   Fan, Chen Yu ^a   Kong, Ling Dong ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Astrogliosis; Betaine; Fructose intake; Metabolic syndrome; Neuroinflammation

Indexed keywords

ANIMALIA; RATTUS;

BETAINE; FRUCTOSE; HISTONE DEACETYLASE; HISTONE DEACETYLASE 3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYD88 PROTEIN, RAT; MYELOID DIFFERENTIATION FACTOR 88; TLR4 PROTEIN, RAT; TOLL LIKE RECEPTOR 4;

ANIMAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GLIOSIS; HYPOTHALAMIC DISEASES; HYPOTHALAMUS; INFLAMMATION; MALE; METABOLISM; NERVE CELL; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; BETAINE; FRUCTOSE; GENE EXPRESSION REGULATION; GLIOSIS; HISTONE DEACETYLASES; HYPOTHALAMIC DISEASES; HYPOTHALAMUS; INFLAMMATION; MALE; MYELOID DIFFERENTIATION FACTOR 88; NEURONS; NF-KAPPA B; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84922780528     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201400307     Document Type: Article

References (63)

1. Tappy, L., Le, K. A., Tran, C., Paquot, N., Fructose and metabolic diseases: new findings, new questions. Nutrition 2010, 26, 1044-1049.
2. Stanhope, K. L., Schwarz, J. M., Keim, N. L., Griffen, S. C. et al., Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J. Clin. Invest. 2009, 119, 1322-1334.
3. Vos, M. B., Lavine, J. E., Dietary fructose in nonalcoholic fatty liver disease. Hepatology 2013, 57, 2525-2531.
4. Johnson, R. J., Nakagawa, T., Sanchez-Lozada, L. G., Shafiu, M. et al., Sugar, uric acid, and the etiology of diabetes and obesity. Diabetes 2013, 62, 3307-3315.
5. Spruss, A., Kanuri, G., Wagnerberger, S., Haub, S. et al., Toll-like receptor 4 is involved in the development of fructose-induced hepatic steatosis in mice. Hepatology 2009, 50, 1094-1104.
6. Qin, B., Polansky, M. M., Harry, D., Anderson, R. A., Green tea polyphenols improve cardiac muscle mRNA and protein levels of signal pathways related to insulin and lipid metabolism and inflammation in insulin-resistant rats. Mol. Nutr. Food Res. 2010, 54(Suppl 1), S14-S23.
7. Palanisamy, N., Kannappan, S., Anuradha, C. V., Genistein modulates NF-kappaB-associated renal inflammation, fibrosis and podocyte abnormalities in fructose-fed rats. Eur. J. Pharmacol. 2011, 667, 355-364.
8. Morton, G. J., Cummings, D. E., Baskin, D. G., Barsh, G. S. et al., Central nervous system control of food intake and body weight. Nature 2006, 443, 289-295.
9. Lopez, M., Varela, L., Vazquez, M. J., Rodriguez-Cuenca, S. et al., Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat. Med. 2010, 16, 1001-1008.
10. Cai, D., Neuroinflammation and neurodegeneration in overnutrition-induced diseases. Trends Endocrinol. Metab. 2013, 24, 40-47.
11. Thaler, J. P., Yi, C. X., Schur, E. A., Guyenet, S. J. et al., Obesity is associated with hypothalamic injury in rodents and humans. J. Clin. Invest. 2012, 122, 153-162.
12. Haydon, P. G., Carmignoto, G., Astrocyte control of synaptic transmission and neurovascular coupling. Physiol. Rev. 2006, 86, 1009-1031.
13. Sofroniew, M. V., Vinters, H. V., Astrocytes: biology and pathology. Acta Neuropathol. 2010, 119, 7-35.
14. Horvath, T. L., Sarman, B., Garcia-Caceres, C., Enriori, P. J. et al., Synaptic input organization of the melanocortin system predicts diet-induced hypothalamic reactive gliosis and obesity. Proc. Natl. Acad. Sci. USA 2010, 107, 14875-14880.
15. la Fleur, S. E., van Rozen, A. J., Luijendijk, M. C., Groeneweg, F. et al., A free-choice high-fat high-sugar diet induces changes in arcuate neuropeptide expression that support hyperphagia. Int. J. Obes. (Lond) 2010, 34, 537-546.
16. Ferraris, R. P., Dietary and developmental regulation of intestinal sugar transport. Biochem. J. 2001, 360, 265-276.
17. Shu, H. J., Isenberg, K., Cormier, R. J., Benz, A. et al., Expression of fructose sensitive glucose transporter in the brains of fructose-fed rats. Neuroscience 2006, 140, 889-895.
18. Arroyo, D. S., Soria, J. A., Gaviglio, E. A., Rodriguez-Galan, M. C. et al., Toll-like receptors are key players in neurodegeneration. Int. Immunopharmacol. 2011, 11, 1415-1421.
19. Okun, E., Griffioen, K. J., Lathia, J. D., Tang, S. C. et al., Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59, 278-292.
20. Owens, T., Toll-like receptors in neurodegeneration. Curr. Top. Microbiol. Immunol. 2009, 336, 105-120.
21. van Noort, J. M., Bsibsi, M., Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog. Brain Res. 2009, 175, 139-148.
22. Bsibsi, M., Ravid, R., Gveric, D., van Noort, J. M., Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61, 1013-1021.
23. Fellner, L., Irschick, R., Schanda, K., Reindl, M. et al., Toll-like receptor 4 is required for alpha-synuclein dependent activation of microglia and astroglia. Glia 2013, 61, 349-360.
24. Yan, Q., Carmody, R. J., Qu, Z., Ruan, Q. et al., Nuclear factor-kappaB binding motifs specify Toll-like receptor-induced gene repression through an inducible repressosome. Proc. Natl. Acad. Sci. USA 2012, 109, 14140-14145.
25. Chen, X., Barozzi, I., Termanini, A., Prosperini, E. et al., Requirement for the histone deacetylase Hdac3 for the inflammatory gene expression program in macrophages. Proc. Natl. Acad. Sci. USA 2012, 109, E2865-E2874.
26. Kannan, V., Brouwer, N., Hanisch, U. K., Regen, T. et al., Histone deacetylase inhibitors suppress immune activation in primary mouse microglia. J. Neurosci. Res. 2013, 91, 1133-1142.
27. Lawless, M. W., Norris, S., O'Byrne, K. J., Gray, S. G., Targeting histone deacetylases for the treatment of immune, endocrine & metabolic disorders. Endocr. Metab. Immune Disord. Drug Targets 2009, 9, 84-107.
28. Sun, Z., Miller, R. A., Patel, R. T., Chen, J. et al., Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat. Med. 2012, 18, 934-942.
29. Winkler, A. R., Nocka, K. N., Williams, C. M., Smoke exposure of human macrophages reduces HDAC3 activity, resulting in enhanced inflammatory cytokine production. Pulm. Pharmacol. Ther. 2012, 25, 286-292.
30. Roglans, N., Vila, L., Farre, M., Alegret, M. et al., Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 2007, 45, 778-788.
31. Zhang, Q. Y., Pan, Y., Wang, R., Kang, L. L. et al., Quercetin inhibits AMPK/TXNIP activation and reduces inflammatory lesions to improve insulin signaling defect in the hypothalamus of high fructose-fed rats. J. Nutr. Biochem. 2014, 25, 420-428.
32. Feldeisen, S. E., Tucker, K. L., Nutritional strategies in the prevention and treatment of metabolic syndrome. Appl. Physiol. Nutr. Metab. 2007, 32, 46-60.
33. Kharbanda, K. K., Mailliard, M. E., Baldwin, C. R., Beckenhauer, H. C. et al., Betaine attenuates alcoholic steatosis by restoring phosphatidylcholine generation via the phosphatidylethanolamine methyltransferase pathway. J. Hepatol. 2007, 46, 314-321.
34. Wang, Z., Yao, T., Pini, M., Zhou, Z. et al., Betaine improved adipose tissue function in mice fed a high-fat diet: a mechanism for hepatoprotective effect of betaine in nonalcoholic fatty liver disease. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298, G634-G642.
35. Song, Z., Deaciuc, I., Zhou, Z., Song, M. et al., Involvement of AMP-activated protein kinase in beneficial effects of betaine on high-sucrose diet-induced hepatic steatosis. Am. J. Physiol. Gastrointest. Liver Physiol. 2007, 293, G894-G902.
36. Abdelmalek, M. F., Sanderson, S. O., Angulo, P., Soldevila-Pico, C. et al., Betaine for nonalcoholic fatty liver disease: results of a randomized placebo-controlled trial. Hepatology 2009, 50, 1818-1826.
37. Abdelmalek, M. F., Angulo, P., Jorgensen, R. A., Sylvestre, P. B. et al., Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: results of a pilot study. Am. J. Gastroenterol. 2001, 96, 2711-2717.
38. Miwa, M., Tsuboi, M., Noguchi, Y., Enokishima, A. et al., Effects of betaine on lipopolysaccharide-induced memory impairment in mice and the involvement of GABA transporter 2. J. Neuroinflammation 2011, 8, 153.
39. Amiraslani, B., Sabouni, F., Abbasi, S., Nazem, H. et al., Recognition of betaine as an inhibitor of lipopolysaccharide-induced nitric oxide production in activated microglial cells. Iran. Biomed. J. 2012, 16, 84-89.
40. Fan, C. Y., Wang, M. X., Ge, C. X., Wang, X. et al., Betaine supplementation protects against high-fructose-induced renal injury in rats. J. Nutr. Biochem. 2014, 25, 353-362.
41. Vilà, L., Roglans, N., Alegret, M., Sánchez, R. M. et al., Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 2008, 48, 1506-1516.
42. Hu, Q. H., Wang, C., Li, J. M., Zhang, D. M. et al., Allopurinol, rutin, and quercetin attenuate hyperuricemia and renal dysfunction in rats induced by fructose intake: renal organic ion transporter involvement. Am. J. Physiol. Renal Physiol. 2009, 297, F1080-F1091.
43. Li, J. M., Li, Y. C., Kong, L. D., Hu, Q. H., Curcumin inhibits hepatic protein-tyrosine phosphatase 1B and prevents hypertriglyceridemia and hepatic steatosis in fructose-fed rats. Hepatology 2010, 51, 1555-1566.
44. Go, E. K., Jung, K. J., Kim, J. Y., Yu, B. P. et al., Betaine suppresses proinflammatory signaling during aging: the involvement of nuclear factor-kappaB via nuclear factor-inducing kinase/IkappaB kinase and mitogen-activated protein kinases. J. Gerontol. A. Biol. Sci. Med. Sci. 2005, 60, 1252-1264.
45. Garcia-Segura, L. M., Torres-Aleman, I., Naftolin, F., Astrocytic shape and glial fibrillary acidic protein immunoreactivity are modified by estradiol in primary rat hypothalamic cultures. Brain Res. Dev. Brain Res. 1989, 47, 298-302.
46. Schwartz, J. P., Wilson, D. J., Preparation and characterization of type 1 astrocytes cultured from adult rat cortex, cerebellum, and striatum. Glia 1992, 5, 75-80.
47. Fantuzzi, G., Dinarello, C. A., Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 1999, 19, 1-11.
48. Craig, S. A., Betaine in human nutrition. Am. J. Clin. Nutr. 2004, 80, 539-549.
49. Moraes, J. C., Coope, A., Morari, J., Cintra, D. E. et al., High-fat diet induces apoptosis of hypothalamic neurons. PLoS One 2009, 4, e5045.
50. Gropp, E., Shanabrough, M., Borok, E., Xu, A. W. et al., Agouti-related peptide-expressing neurons are mandatory for feeding. Nat. Neurosci. 2005, 8, 1289-1291.
51. Lindqvist, A., Baelemans, A., Erlanson-Albertsson, C., Effects of sucrose, glucose and fructose on peripheral and central appetite signals. Regul. Pept. 2008, 150, 26-32.
52. Rossi, J., Balthasar, N., Olson, D., Scott, M. et al., Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis. Cell Metab. 2011, 13, 195-204.
53. Siljee, J. E., Unmehopa, U. A., Kalsbeek, A., Swaab, D. F. et al., Melanocortin-4 receptor distribution in the human hypothalamus. Eur. J. Endocrinol. 2012, 168, 361-369.
54. Li, J., Tang, Y., Cai, D., IKKbeta/NF-kappaB disrupts adult hypothalamic neural stem cells to mediate a neurodegenerative mechanism of dietary obesity and pre-diabetes. Nat. Cell Biol. 2012, 14, 999-1012.
55. Fuente-Martin, E., Garcia-Caceres, C., Granado, M., de Ceballos, M. L. et al., Leptin regulates glutamate and glucose transporters in hypothalamic astrocytes. J. Clin. Invest. 2012, 122, 3900-3913.
56. Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. et al., Glial cells in (patho)physiology. J. Neurochem. 2012, 121, 4-27.
57. Wagnerberger, S., Spruss, A., Kanuri, G., Stahl, C. et al., Lactobacillus casei Shirota protects from fructose-induced liver steatosis: a mouse model. J. Nutr. Biochem. 2013, 24, 531-538.
58. Zhang, W., Wang, L. W., Wang, L. K., Li, X. et al., Betaine protects against high-fat-diet-induced liver injury by inhibition of high-mobility group box 1 and Toll-like receptor 4 expression in rats. Dig. Dis. Sci. 2013, 58, 3198-3206.
59. Funato, H., Oda, S., Yokofujita, J., Igarashi, H. et al., Fasting and high-fat diet alter histone deacetylase expression in the medial hypothalamus. PLoS One 2011, 6, e18950.
60. Li, Q., Verma, I. M., NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2002, 2, 725-734.
61. Viatour, P., Legrand-Poels, S., van Lint, C., Warnier, M. et al., Cytoplasmic IkappaBalpha increases NF-kappaB-independent transcription through binding to histone deacetylase (HDAC) 1 and HDAC3. J. Biol. Chem. 2003, 278, 46541-46548.
62. van Wijk, N., Watkins, C. J., Bohlke, M., Maher, T. J. et al., Plasma choline concentration varies with different dietary levels of vitamins B6, B12 and folic acid in rats maintained on choline-adequate diets. Br. J. Nutr. 2012, 107, 1408-1412.
63. Jadavji, N. M., Bahous, R. H., Deng, L., Malysheva, O. et al., Mouse model for deficiency of methionine synthase reductase exhibits short-term memory impairment and disturbances in brain choline metabolism. Biochem. J. 2014, 461, 205-212.